首页> 外文会议>International Conference on Swarm Intelligence >Using the Encoder Embedded Framework of Dimensionality Reduction Based on Multiple Drugs Properties for Drug Recommendation
【24h】

Using the Encoder Embedded Framework of Dimensionality Reduction Based on Multiple Drugs Properties for Drug Recommendation

机译:基于多种药物建议的多种药物特性,使用编码器嵌入框架的维度减少框架

获取原文

摘要

After obtaining a large amount of drug information, how to extract the most important features from various high-dimensional attribute datasets for drug recommendation has become an important task in the initial stage of drug repositioning. Dimensionality reduction is a necessary and important task for getting the best features in next step. In this paper, three important attribute data about the drugs (i.e., chemical structures, target proteins and side effects) are selected, and two deep frameworks named as F_1 and F_2 are used to accomplish the task of dimensionality reduction. The processed data are used for recommending new indications by collaborative filtering algorithm. In order to compare the results, two important values of Mean Absolute Error (MAE) and Coverage are selected to evaluate the performance of the two frameworks. Through the comparison with the results of Principal Components Analysis (PCA), it shows that the two deep frameworks proposed in this paper perform better than PCA and can be used for dimensionality reduction task in the future in drug repositioning.
机译:在获得大量的药物信息后,如何提取来自各种高维属性数据集的最重要的特征,用于药品推荐已成为药物重新定位初始阶段的重要任务。减少维度是在下一步中获得最佳功能的必要和重要任务。在本文中,选择了关于药物(即化学结构,靶蛋白和副作用)的三个重要属性数据,并且使用两个名为F_1和F_2的深框架来实现维数减少的任务。处理后的数据用于通过协同过滤算法推荐新指示。为了比较结果,选择两个均值的两个重要值和覆盖范围以评估两个框架的性能。通过与主成分分析(PCA)的结果进行比较,它表明本文提出的两个深框架比PCA更好,可用于未来在药物重新定位中的维度减少任务。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号